Citation: Bm. Cohen et D. Yurgelun-todd, Alterations of thalamic activity in schizophrenia and in response to antipsychotic drugs - Studies in the legacy of Seymour S. Kety, NEUROPSYCH, 25(3), 2001, pp. 305-312
Authors:
Kaufman, MJ
Levin, JM
Maas, LC
Kukes, TJ
Villafuerte, RA
Dostal, K
Lukas, SE
Mendelsohn, JH
Cohen, BM
Renshaw, PF
Citation: Mj. Kaufman et al., Cocaine-induced cerebral vasoconstriction differs as a function of sea andmenstrual cycle phase, BIOL PSYCHI, 49(9), 2001, pp. 774-781
Authors:
Renshaw, PF
Parow, AM
Hirashima, F
Ke, Y
Moore, CM
Frederick, BD
Fava, M
Hennen, J
Cohen, BM
Citation: Pf. Renshaw et al., Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression, AM J PSYCHI, 158(12), 2001, pp. 2048-2055
Authors:
Moore, CM
Breeze, JL
Gruber, SA
Babb, SM
Frederick, BD
Villafuerte, RA
Stoll, AL
Hennen, J
Yurgelun-Todd, DA
Cohen, BM
Renshaw, PF
Citation: Cm. Moore et al., Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex, BIPOL DIS, 2(3), 2000, pp. 207-216
Citation: Y. Ke et al., Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy, PSYCH RES-N, 100(3), 2000, pp. 169-178
Authors:
Christensen, JD
Kaufman, MJ
Frederick, BD
Rose, SL
Moore, CM
Lukas, SE
Mendelson, JH
Cohen, BM
Renshaw, PF
Citation: Jd. Christensen et al., Proton magnetic resonance spectroscopy of human basal ganglia: Response tococaine administration, BIOL PSYCHI, 48(7), 2000, pp. 685-692
Authors:
Tohen, M
Strakowski, SM
Zarate, C
Hennen, J
Stoll, AL
Suppes, T
Faedda, GL
Cohen, BM
Gebre-Medhin, P
Baldessarini, RJ
Citation: M. Tohen et al., The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and noneffective psychosis, BIOL PSYCHI, 48(6), 2000, pp. 467-476
Authors:
Henry, ME
Moore, CM
Kaufman, MJ
Michelson, D
Schmidt, ME
Stoddard, E
Vuckevic, AJ
Berreira, PJ
Cohen, BM
Renshaw, PF
Citation: Me. Henry et al., Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: A fluorine MRS study, AM J PSYCHI, 157(9), 2000, pp. 1506-1508
Authors:
Tohen, M
Hennen, J
Zarate, CM
Baldessarini, RJ
Strakowski, SM
Stoll, AL
Faedda, GL
Suppes, T
Gebre-Medhin, P
Cohen, BM
Citation: M. Tohen et al., Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features, AM J PSYCHI, 157(2), 2000, pp. 220-228
Citation: Mj. Kaufman et al., Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance, PSYCH RES-N, 90(3), 1999, pp. 143-152
Authors:
Mendelson, JH
Mello, NK
Sholar, MB
Siegel, AJ
Kaufman, MJ
Levin, JM
Renshaw, PF
Cohen, BM
Citation: Jh. Mendelson et al., Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle, NEUROPSYCH, 21(2), 1999, pp. 294-303
Authors:
Baird, AA
Gruber, SA
Fein, DA
Maas, LC
Steingard, RJ
Renshaw, PF
Cohen, BM
Yurgelun-Todd, DA
Citation: Aa. Baird et al., Functional magnetic resonance imaging of facial affect recognition in children and adolescents, J AM A CHIL, 38(2), 1999, pp. 195-199
Authors:
Christensen, JD
Yurgelun-Todd, DA
Babb, SM
Gruber, SA
Cohen, BM
Renshaw, PF
Citation: Jd. Christensen et al., Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy, BRAIN RES, 834(1-2), 1999, pp. 1-5
Authors:
Moore, CM
Breeze, JL
Kukes, TJ
Rose, SL
Dager, SR
Cohen, BM
Renshaw, PF
Citation: Cm. Moore et al., Effects of myo-Inositol ingestion on human brain myo-inositol levels: A proton magnetic resonance spectroscopic imaging study, BIOL PSYCHI, 45(9), 1999, pp. 1197-1202